We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Astech Projects Provides Leading Pharmaceutical Company with Bespoke Analytical Technology Platforms
Product News

Astech Projects Provides Leading Pharmaceutical Company with Bespoke Analytical Technology Platforms

Astech Projects Provides Leading Pharmaceutical Company with Bespoke Analytical Technology Platforms
Product News

Astech Projects Provides Leading Pharmaceutical Company with Bespoke Analytical Technology Platforms


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Astech Projects Provides Leading Pharmaceutical Company with Bespoke Analytical Technology Platforms"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A successful collaboration between the leading automation systems developer, Astech Projects with a pioneering research-based pharmaceutical and healthcare company has been detailed in the poster, entitled ‘Technology Implementation for Analysis of Inhaled Products’.

Having been recently presented at the Drug Delivery to the Lungs (DDL) conference and exhibition, the poster details how bespoke analytical technology platforms in support of Dry Powder Inhaler (DPI) testing have been implemented within the GlaxoSmithKline (GSK) inhaled testing laboratories using a Quality by Design approach.

Using Astech’s specialist automation expertise, these bespoke analytical technology platforms were developed to deliver effective, efficient and safe testing.

In comparison to the manual procedures previously employed, the newly developed platforms increase throughput by substantially reducing the time taken to perform 100 samples and minimize analytical variability.

In addition, use of the automated platforms decrease the volume of solvent needed for testing, which in turn reduces the waste streams resulting in greener, more cost-effective testing. View the poster for full details.

Advertisement